SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-21-008000
Filing Date
2021-11-10
Accepted
2021-11-10 16:14:14
Documents
15
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vnrx_8k.htm   iXBRL 8-K 27077
2 PRESS RELEASE vnrx_ex991.htm EX-99.1 40820
  Complete submission text file 0001477932-21-008000.txt   204849

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20211110.xsd EX-101.SCH 5595
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20211110_lab.xml EX-101.LAB 15362
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20211110_cal.xml EX-101.CAL 890
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20211110_pre.xml EX-101.PRE 9785
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20211110_def.xml EX-101.DEF 2097
8 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_8k_htm.xml XML 3730
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 211396751
SIC: 2835 In Vitro & In Vivo Diagnostic Substances